Stock Analysis

We're Not Very Worried About PolyNovo's (ASX:PNV) Cash Burn Rate

ASX:PNV
Source: Shutterstock

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, PolyNovo (ASX:PNV) has seen its share price rise 260% over the last year, delighting many shareholders. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?

Given its strong share price performance, we think it's worthwhile for PolyNovo shareholders to consider whether its cash burn is concerning. For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. Let's start with an examination of the business's cash, relative to its cash burn.

See our latest analysis for PolyNovo

Advertisement

How Long Is PolyNovo's Cash Runway?

You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. In June 2019, PolyNovo had AU$14m in cash, and was debt-free. In the last year, its cash burn was AU$9.9m. So it had a cash runway of approximately 17 months from June 2019. That's not too bad, but it's fair to say the end of the cash runway is in sight, unless cash burn reduces drastically. Depicted below, you can see how its cash holdings have changed over time.

ASX:PNV Historical Debt, October 1st 2019
ASX:PNV Historical Debt, October 1st 2019

How Well Is PolyNovo Growing?

At first glance it's a bit worrying to see that PolyNovo actually boosted its cash burn by 39%, year on year. On a more positive note, the operating revenue improved by 114% over the period, offering an indication that the expenditure may well be worthwhile. If that revenue does keep flowing reliably, then the company could see a strong improvement in free cash flow simply by reducing growth expenditure. We think it is growing rather well, upon reflection. Clearly, however, the crucial factor is whether the company will grow its business going forward. For that reason, it makes a lot of sense to take a look at our analyst forecasts for the company.

Can PolyNovo Raise More Cash Easily?

While PolyNovo seems to be in a fairly good position, it's still worth considering how easily it could raise more cash, even just to fuel faster growth. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. Commonly, a business will sell new shares in itself to raise cash to drive growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations.

PolyNovo has a market capitalisation of AU$1.4b and burnt through AU$9.9m last year, which is 0.7% of the company's market value. That means it could easily issue a few shares to fund more growth, and might well be in a position to borrow cheaply.

Is PolyNovo's Cash Burn A Worry?

It may already be apparent to you that we're relatively comfortable with the way PolyNovo is burning through its cash. For example, we think its revenue growth suggests that the company is on a good path. Although its increasing cash burn does give us reason for pause, the other metrics we discussed in this article form a positive picture overall. Based on the factors mentioned in this article, we think its cash burn situation warrants some attention from shareholders, but we don't think they should be worried. When you don't have traditional metrics like earnings per share and free cash flow to value a company, many are extra motivated to consider qualitative factors such as whether insiders are buying or selling shares. Please Note: PolyNovo insiders have been trading shares, according to our data. Click here to check whether insiders have been buying or selling.

Of course PolyNovo may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

About ASX:PNV

PolyNovo

Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.

High growth potential with proven track record.

Advertisement